Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Arnott

Showing results (71-80 of 164) with videos related to

Pageof 17
Sort By:
Gastroenterology|March 5, 2002
Successful infliximab treatment for steroid-refractory celiac disease: a case reportHelen R Gillett, Ian D R Arnott, Margaret McIntyre, et al.
Gut|June 13, 2003
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trialC S J Probert, S D Hearing, S Schreiber, et al.
Hearing Research|November 13, 2015
Attentional modulation of informational masking on early cortical representations of speech signalsChangxin Zhang, Stephen R Arnott, Cristina Rabaglia, et al.
Frontline Gastroenterology|August 26, 2017
The organisation and structure of inflammatory bowel disease services for children and young people in the UK in 2010: significant progress but still room for improvementMichael P Fitzgerald, Sally G Mitton, Aimee Protheroe, et al.
Alimentary Pharmacology & Therapeutics|October 15, 2013
A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysisN A Kennedy, E Rhatigan, I D R Arnott, et al.
The American Journal of Gastroenterology|March 7, 2007
Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitisMarian C Aldhous, Hazel E Drummond, Niall Anderson, et al.
The American Journal of Gastroenterology|December 2, 2004
Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotypeIan D R Arnott, Carol J Landers, Elaine J Nimmo, et al.
Clinical and Experimental Immunology|March 11, 2004
Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutationsL J Walker, M C Aldhous, H E Drummond, et al.
Canine Genetics and Epidemiology|September 25, 2015
Strong selection for behavioural resilience in Australian stock working dogs identified by selective sweep analysisElizabeth R Arnott, Lincoln Peek, Jonathan B Early, et al.
BMJ Open|July 10, 2023
Bridging that gap: a qualitative study of perceptions of equality, diversity and inclusivity in colorectal surgery in the UK and IrelandDeena Harji, Panchali Sarmah, Bethany Gwyther, et al.
Pageof 17

Showing results (71-80 of 164) with videos related to

Sort By:
Pageof 17
Gastroenterology|March 5, 2002
Successful infliximab treatment for steroid-refractory celiac disease: a case reportHelen R Gillett, Ian D R Arnott, Margaret McIntyre, et al.
Gut|June 13, 2003
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trialC S J Probert, S D Hearing, S Schreiber, et al.
Hearing Research|November 13, 2015
Attentional modulation of informational masking on early cortical representations of speech signalsChangxin Zhang, Stephen R Arnott, Cristina Rabaglia, et al.
Frontline Gastroenterology|August 26, 2017
The organisation and structure of inflammatory bowel disease services for children and young people in the UK in 2010: significant progress but still room for improvementMichael P Fitzgerald, Sally G Mitton, Aimee Protheroe, et al.
Alimentary Pharmacology & Therapeutics|October 15, 2013
A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysisN A Kennedy, E Rhatigan, I D R Arnott, et al.
The American Journal of Gastroenterology|March 7, 2007
Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitisMarian C Aldhous, Hazel E Drummond, Niall Anderson, et al.
The American Journal of Gastroenterology|December 2, 2004
Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotypeIan D R Arnott, Carol J Landers, Elaine J Nimmo, et al.
Clinical and Experimental Immunology|March 11, 2004
Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutationsL J Walker, M C Aldhous, H E Drummond, et al.
Canine Genetics and Epidemiology|September 25, 2015
Strong selection for behavioural resilience in Australian stock working dogs identified by selective sweep analysisElizabeth R Arnott, Lincoln Peek, Jonathan B Early, et al.
BMJ Open|July 10, 2023
Bridging that gap: a qualitative study of perceptions of equality, diversity and inclusivity in colorectal surgery in the UK and IrelandDeena Harji, Panchali Sarmah, Bethany Gwyther, et al.
Pageof 17